A senior official from the National Institutes of Health (NIH) recently addressed researchers at the American Diabetes Association (ADA) conference, promoting the MAHA strategy.
The advisor emphasized that the goals of the MAHA initiative correspond with the NIH's priorities, aiming to foster collaboration and innovation in diabetes research.
However, the reception to this strategy was mixed, with some attendees expressing skepticism regarding its feasibility and effectiveness in addressing current challenges in diabetes care.